<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000269431"><TermName>Virulizin</TermName><TermPronunciation>(VEER-yoo-LY-zin)</TermPronunciation><TermDefinition><DefinitionText>A substance that activates some types of immune system cells, and is being studied as a treatment for cancer. It belongs to the family of drugs called biological therapy agents.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731435" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Virulizin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731434" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Virulizin&quot;" language="es" id="_4"/><SpanishTermName>Virulizin</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia que activa algunos tipos de células inmunitarias y que está en estudio para el tratamiento del cáncer. Es un tipo de medicamento usado en la terapia biológica.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2002-12-21</DateFirstPublished></GlossaryTerm>
